|
|
|
|
| LEADER |
02732nam a22005175i 4500 |
| 001 |
978-1-4939-0261-3 |
| 003 |
DE-He213 |
| 005 |
20151030151012.0 |
| 007 |
cr nn 008mamaa |
| 008 |
140227s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493902613
|9 978-1-4939-0261-3
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-0261-3
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a QH506
|
| 072 |
|
7 |
|a MBGR
|2 bicssc
|
| 072 |
|
7 |
|a PSD
|2 bicssc
|
| 072 |
|
7 |
|a SCI049000
|2 bisacsh
|
| 072 |
|
7 |
|a MED067000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 611.01816
|2 23
|
| 245 |
1 |
0 |
|a Clinical Applications of Botulinum Neurotoxin
|h [electronic resource] /
|c edited by Keith A. Foster.
|
| 264 |
|
1 |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a XI, 196 p. 12 illus., 8 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Current Topics in Neurotoxicity ;
|v 5
|
| 505 |
0 |
|
|a Botulinum Toxin as a Clinical Product -- Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders -- Clinical Use of Botulinum Neurotoxin: Autonomic Conditions -- Clinical Use of Botulinum Neurotoxin: Urogenital Disorders Including Overactive Bladder -- Clinical Use of Botulinum Neurotoxins: Pain -- Future Developments: Engineering the Neurotoxin. .
|
| 520 |
|
|
|a Currently, there are tremendous advances being made in understanding the basic science of both the structure and function of botulinum neurotoxins. This knowledge is opening up opportunities in regard to both therapeutic uses and treatment and protection options for civil and bio-defense applications. This volume fully evaluates the status of neurotoxin research and exploitation, with a focus on clinical application. The book is a multi-authored collection of chapters written by the leading authorities responsible for the current scientific and clinical research that is advancing the understanding and exploitation of the neurotoxins, and is both up to date and authoritative.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Molecular Medicine.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Biomedicine general.
|
| 650 |
2 |
4 |
|a Neurosciences.
|
| 700 |
1 |
|
|a Foster, Keith A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9781493902606
|
| 830 |
|
0 |
|a Current Topics in Neurotoxicity ;
|v 5
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-4939-0261-3
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
